Pain is typically ranked by both patients and physicians as the most important symptom of psoriatic arthritis (PsA) to assess and treat. Although the predominant concept of the etiology of pain in PsA is that of inflammation in peripheral joints, entheses, and bone signaling through peripheral nociceptive fibers, perceived as pain in the central nervous system, it is actually more complex than that. The ability of a treatment to ameliorate
It's not a simple matter to prescribe tumor necrosis factor (TNF) inhibitors for patients with juvenile idiopathic arthritis (JIA), at least those with insurance, a single-center study found.
Among 54 patients seen at Boston Children's Hospital for newly diagnosed JIA in 2018-2019, their insurers required prior authorization for all but one, according to researchers there led by Jordan E. Roberts, MD.
Mayo Clinic Proceedings reports the results of a retrospective, cross-sectional of patients with HFE hemochromatosis showing that advanced hepatic fibrosis is primarily seen in those with arthritis due to HFE hemochromatosis.
Dr. John Cush RheumNow
4 years 5 months ago
FDA approved 1st drug for kids with COVID-19. Veklury (remdesivir) get an expanded indication in Peds >28days old & wt > 3 kg who has SARS-CoV-2 & are Hospitalized, or Not hospitalized & at high risk for severe COVID-19 or death https://t.co/7Hn4CwKjxv
Dr. John Cush RheumNow
4 years 5 months ago
COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients
Putman et al has reported vaccine survey results from the C19-GRA in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD).
https://t.co/sqsOHGThzV https://t.co/zeZrlDeQ9Z
Dr. John Cush RheumNow
4 years 5 months ago
One centers experience with a combined Rheum-Derm Clinic. Among 151 psoriasis patients with suspicious musculoskeletal complaints, 85% were dx w/ PsA - 62% of these PsA was 1st diagnosed. https://t.co/RcQrWaXTWj
Dr. John Cush RheumNow
4 years 5 months ago
QD Clinic - PsA lessons and cases from the Rheumatology clinic.
Distinguishing Psoriatic arthritis from Erosive Osteoarthritis can be difficult
https://t.co/UCcCMqUL2d https://t.co/zLkfBYI4Cm
Dr. John Cush RheumNow
4 years 5 months ago
Open label, RCT compared triple DMARD Rx adding either LEF (MLH) or SSZ (MSH) to MTX+HCQ in 136 RA pts. Both were equally effective (non-inferior), 61.7% & 64.7% patients (pā=ā0.8) at wk 24. AE were also equal (15 vs 21 AE). https://t.co/ZucrYKuNms
Dr. John Cush RheumNow
4 years 5 months ago
Mark your calendars for our next Tuesday Night Rheumatology on 4/26 at 7pm!
Speakers will include:
Dr. Eric Ruderman
Dr. Arthur Kavanaugh
Dr. David Liew
Dr. Jack Cush
https://t.co/by1xtmPSZ0
You can also find us LIVE on YouTube, Twitter, and Facebook. https://t.co/o633KHx81b
Dr. John Cush RheumNow
4 years 5 months ago
ICYMI:Faith in Exercise Benefit Boosts Actual Benefit in SpA
https://t.co/kEErN5IZUI https://t.co/9ve0ey9MRp
Dr. John Cush RheumNow
4 years 5 months ago
Global Rheumatology Therapeutics (drug) Market size is estimated to be $29.37 billion (USD) in 2022, and is projected to grow to $40.13 billion by 2027. https://t.co/JDzkYFENFc
Dr. John Cush RheumNow
4 years 5 months ago
ICYMI: Axial Disease in Psoriatic Arthritis
Inflammatory involvement of the axial skeleton and sacroiliac joints occurs, on average, in 40-50% of patients with psoriatic arthritis (PsA).
https://t.co/QKtpSPDz5V https://t.co/ROz5o9OTyZ
Dr. John Cush RheumNow
4 years 5 months ago
QD clinic - PsA Lessons from Patients
Enthesitis in a 14 yr.old - management and evolutionary possibilities
https://t.co/MtgoDXJ7EF https://t.co/sTFyySF4vl
Dr. John Cush RheumNow
4 years 5 months ago
Did you missed this past Tuesday Night Rheumatology? We have the playback available now.
The PsA Expert panelists included: Dr. Dafna Gladman Dr. Joseph Merola, Dr. Peter Nash, Dr. Christopher Ritchlin, Dr. Jose Scher and Dr. Jack Cush.
https://t.co/u5lt2uDoGK https://t.co/lOmN4OoGLi
Dr. John Cush RheumNow
4 years 5 months ago
COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients
Putman et al has reported vaccine survey results from the C19-GRA in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD).
https://t.co/fIHAhpvVho https://t.co/6tFbQd0vJQ

